Cubist Systematic Strategies, LLC Regeneron Pharmaceuticals, Inc. Put Options Transaction History

Cubist Systematic Strategies, LLC

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$1024.09 - $1201.76 $3.38 Million - $3.97 Million	3,300 New	3,300 $3.47 Million
Q1 2024 May 15, 2024	SELL	$902.69 - $993.35 $11 Million - $12.1 Million	-12,200 Reduced 66.67%	6,100 $5.87 Million
Q4 2023 Feb 14, 2024	SELL	$775.18 - $881.7 $930,215 - $1.06 Million	-1,200 Reduced 6.15%	18,300 $16.1 Million
Q3 2023 Nov 14, 2023	BUY	$692.45 - $844.37 $553,960 - $675,496	800 Added 4.28%	19,500 $16 Million
Q2 2023 Aug 14, 2023	BUY	$700.03 - $830.35 $2.24 Million - $2.66 Million	3,200 Added 20.65%	18,700 $13.4 Million
Q1 2023 May 15, 2023	BUY	$680.49 - $826.97 $6.33 Million - $7.69 Million	9,300 Added 150.0%	15,500 $12.7 Million
Q4 2022 Feb 14, 2023	BUY	$705.89 - $766.39 $4.38 Million - $4.75 Million	6,200 New	6,200 $4.47 Million

1,534

83.6M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $75.2B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.